Intellia Therapeutics (NASDAQ:NTLA) has outperformed the market over the past 5 years by 19.59% on an annualized basis.
Buying $100 In NTLA: 5 years ago, an investor could have purchased 6.95 shares of Intellia Therapeutics at the time with $100. This investment in NTLA would have produced an average annual return of 31.86%. Currently, Intellia Therapeutics has a market capitalization of $4.27 billion.
